Notice Number: NOT-CA-06-021
Key Dates
Release Date: March 21, 2006
Issued by
National Cancer Institute (NCI), (http://www.cancer.gov/)
Amendments
The National Cancer Institute hereby informs all interested parties that Program Announcement PAR-05-156, Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2006, is amended as follows:
Please also note that the June 1, 2006 , receipt date for P50 grant applications for SPOREs covering Gastrointestinal Cancer, Brain Tumor, and Lymphoma remains the same ; P50 SPORE applications covering cancers of other (additional) organ sites are not and will not be allowed on that receipt date.
This Notice does not affect any other aspects of the original PAR-05-156. Please refer to the original announcement for further instructions.
All receipt dates in the Year 2007 re-issuance of the full SPORE Program Announcement will be open for the submission of new, renewal, and resubmission P50 applications for all listed organ sites.
Current P50 SPORE grantees/awardees must adhere to the end dates for their renewal applications and such applications can only be submitted for funding in the year that the current award is due to expire. Renewal applications that are submitted early will be returned to applicants without review. Current awardees can contact their assigned Program Directors in the Organ Systems Branch for the appropriate receipt dates for their competing renewal applications.
Inquiries
Direct any questions about this Notice to:
Jorge Gomez, M.D., Ph.D.
Branch Chief
Organ Systems Branch
Office of Centers, Training, and Resources
National Cancer Institute
6116 Executive Boulevard, Suite 7013, MSC 7013
Bethesda, MD 20892-8345 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Telephone: (301) 496-8528
FAX: (301) 402-5319
Email: jg1w@nih.gov
Send Letters of Intent to the persons indicated below via e-mail, fax, mail, or courier.
For Breast, Ovarian, and Gynecologic Cancer SPOREs, the Letter of Intent to submit a P50 application should be directed to:
Jorge Gomez, M.D., Ph.D.
Email: jg1w@nih.gov
For Gastrointestinal, Pancreas, Skin, Head & Neck Cancer SPOREs , the Letter of Intent to submit a P50 application should be directed to:
Ivan Ding , M.D.
Email: dingi@mail.nih.gov
For Lung Cancer, Brain Tumors, Leukemia, Lymphoma, and Myeloma SPOREs , the Letter of Intent to submit a P50 application should be directed to:
Peter Ujhazy M.D. , Ph.D.
Email: ujhazyp@mail.nih.gov
For Prostate and Genitourinary Cancer SPOREs , the Letter of Intent to submit a P50 application should be directed to:
Andrew Hruszkewycz , M.D. , Ph.D.
Email: hruszkea@mail.nih.gov
Organ Systems Branch
Office of Centers, Training, and Resources
National Cancer Institute
6116 Executive Boulevard, Suite 7013, MSC 7013
Bethesda, MD 20892-8345 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)
Telephone: (301) 496-8528
FAX: (301) 402-5319
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
![]() |
Office of Extramural Research (OER) |
![]() |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
![]() |
Department of Health and Human Services (HHS) |
![]() |
||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |